Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Frederick J. Raal et al.|European Heart Journal|2017Cited by 3.8k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementFlorian Kronenberg, Alberico L. Catapano, Samia Mora et al.|European Heart Journal|2022Cited by 1.3k
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis SocietyHenry N. Ginsberg, Alberico L. Catapano, Chris J. Packard et al.|European Heart Journal|2021Cited by 889
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Kausik K. Ray, Frederick J. Raal et al.|European Heart Journal|2023Cited by 329